Create sustained value for investors
Shanghai Hepu Pharmaceutical Co., Ltd. was jointly established by Shanghai Zhangjiang Biopharmaceutical Industry Venture Capital Co., Ltd., Shanghai Yuanxu Investment Management Co., Ltd. and Shanghai Hepu Biotechnology Co., Ltd. in November 2013. The fund withdrew after its expiration in March 2018.
The company strengthens information communication with investors, deepens investors' understanding and recognition of the company, promotes the benign relationship between the company and investors, establishes the company's integrity among the investing public, and enhances the company's investment value to benefit Improve the corporate governance structure, improve the company's core competitiveness, maximize the company's value and maximize the interests of shareholders, and effectively protect the interests of investors.